MDB Capital/Media Reports MDB Capital and the companies it supports share information and insights to help educate investors on technologies and the business categories and segments that impact them. 07.23.2026 What Is OpenAI Actually Patenting? 06.30.2026 The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1 06.04.2026 The Muscle Problem: How Myostatin Could Expand the GLP-1 Opportunity 04.28.2026 The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market. 03.25.2026 The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine 02.26.2026 The Oral Small-Molecule GLP-1 Race: Beyond Orforglipron 01.15.2026 The Patent Battlefield: How IP Portfolios Reveal the True Winners in the $1.8 Trillion Space Economy 10.28.2025 The State Of Cardiac Technology: The Path To Total Cardiac Intelligence 08.19.2025 Quantum Computing at the Inflection Point: Who’s Leading, What They Own, and Why IP Decides Quantum’s Future 07.10.2025 The Next Era of Surgical Robotics: Market Fragmentation, Strategic Signals, and IP Leadership 06.02.2025 MDBH Comprehensive Backtesting Analysis of Investment Strategies- May 2025 05.19.2025 Humanoid Robots: The Disconnect Between IP Strength And VC Funding Of US And European Humanoid Robot Startups Up Next | About MDB >
